iTAG MHC Mart 1 Tetramer Technology

Company
Beckman Coulter, Inc.
Use
iTAg reagents allow for measurement against one specific peptide
Features
Suitable for basic and clinical research in a number of applications including drug / vaccine development.
NIH Contribution
Discovered a nucleic acid sequence encoding a melanoma antigen recognized by T lymphocytes, designated MART-1.
HHS Institute/Agency
NCI
Inventor(s)
S. Rosenberg, Y. Kawakami
Year
2005
Tech Cat
Research Reagent